Clinical Trial Update: Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the role of dialysate magnesium in reducing arrhythmia risk during dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Chronic Kidney Disease

Snippet

Sponsor: University of Michigan | Conditions: Chronic Kidney Disease, Arrhythmia | Phase 2 | Status: COMPLETED